Cannabis – from hippie drug to medical hype (SRF, 25.04.2022)
| | | |

Cannabis – from hippie drug to medical hype (SRF, 25.04.2022)

The SRF documentary on Medical Cannabis provides an overview on the current market situation Key takeouts: good results on patients using the medicine high prices for patient due to 1 company dominant position flowers are not yet available as medicine (it will only be available with the #pilotprojects medical Cannabis still need to evolve from…

Medical cannabis available by prescription
|

Medical cannabis available by prescription

Starting this summer, it will be easier to get a prescription for medical cannabis. But watch your wallet, because it won’t be automatically reimbursed. Cannabis-based medicines will soon be available by prescription, without the need for exceptional authorization from the Federal Office of Public Health (FOPH). This legislative change will probably come into force in…

Analysis of the Swiss chemists’ statement saying most CBD cannabis products fail to meet standards. However, it only concerns food and veterinary products.
| |

Analysis of the Swiss chemists’ statement saying most CBD cannabis products fail to meet standards. However, it only concerns food and veterinary products.

On February 1st 2022, the Swiss Association of Cantonal Chemists, announced in a press release that, in Switzerland, the vast majority of products sold containing the cannabis extract cannabidiol (CBD) do not meet legal requirements. It was relayed across many media channels, such as swissinfo stating that Most CBD cannabis products fail to meet standards. However, these findings do not apply to the medical/therapeutic cannabis.

Implementing ordinance for facilitated access to treatments with medicinal cannabis in the consultation process
|

Implementing ordinance for facilitated access to treatments with medicinal cannabis in the consultation process

Bern, 25.08.2021 – At its meeting on August 25, 2021, the Federal Council opened the consultation on the implementation of the amendment to the Narcotics Act (BetmG) passed by Parliament. The amendment is intended to facilitate access to treatments with therapeutic cannabis. In the future, a prescription will no longer require the granting of an exceptional authorization from the Federal Office of Public Health (FOPH). Cannabis for consumption purposes, on the other hand, will continue to be prohibited.

Medical Cannabis – Adoption of the Amendment to the Swiss Law on Narcotic Drugs (Cannabis-based medicines)

Medical Cannabis – Adoption of the Amendment to the Swiss Law on Narcotic Drugs (Cannabis-based medicines)

Bern, 08.03.2021 – The Council of States adopts the amendment to the Swiss Law on Narcotic Drugs and Psychotropic Substances. Access to medical cannabis will be made easier, as an exceptional authorisation from the FOPH for its use will no longer be required.